Latest News in the pharma Industry

All

GSK delivers double-edged sword

GSK delivers double-edged sword

19 Jul 2017

Company announces investments, the sale of several products and a proposal to close a UK manufacturing site.

Read more 
South Korean pharma rapidly becoming manufacturing export hub

South Korean pharma rapidly becoming manufacturing export hub

19 Jul 2017

Overseas buyers at CPhI Korea double in the past 2 years.

Read more 
VIO Chemicals: Swiss excellence encompassing low-cost European R&D expertise and advanced manufacturing in China for high-performance products

VIO Chemicals: Swiss excellence encompassing low-cost European R&D expertise and advanced manufacturing in China for high-performance products

18 Jul 2017

VIO Chemicals is an exclusive contract development and manufacturing organisation for specialty chemicals,  intermediates and Active Pharmaceutical Ingredients (APIs). Founded in Zurich in 2001, VIO Chemicals carries a long history of high-...

Read more 
Transfer technology expert expands US presence following multi-million-pound investment

Transfer technology expert expands US presence following multi-million-pound investment

18 Jul 2017

Investment follows demand for the company's AseptiSafe and PharmaSafe product ranges, which transfer APIs in small- and large-scale pharmaceutical manufacturing environments.

Read more 
FDA approves new treatment to reduce the risk of breast cancer returning

FDA approves new treatment to reduce the risk of breast cancer returning

18 Jul 2017

Nerlynx is the first extended adjuvant therapy for patients with HER2-positive breast cancer.

Read more 
Shire expands broad monoclonal antibody research platform

Shire expands broad monoclonal antibody research platform

18 Jul 2017

Shire obtains worldwide license to pursue development and commercialization of a novel, potentially differentiated, pre-clinical bi-specific antibody candidate for Hemophilia A.

Read more 
Amgen and Array BioPharma announce preclinical license and collaboration agreement in inflammation

Amgen and Array BioPharma announce preclinical license and collaboration agreement in inflammation

18 Jul 2017

Array to advance preclinical program for autoimmune disorders; Amgen responsible for clinical development and worldwide commercialization.

Read more 
Technology adoption fuels growth for pharma tech firm

Technology adoption fuels growth for pharma tech firm

17 Jul 2017

Company has experienced double digit growth across its automation, MES and managed services offering.

Read more 
Catalent launches new OptiForm Solution Suite

Catalent launches new OptiForm Solution Suite

17 Jul 2017

The service offers quick and efficient path from late-stage discovery to Phase I clinical trials.

Read more 
FDA approves Impax's AB rated generic Concerta Extended-Release Tablets CII

FDA approves Impax's AB rated generic Concerta Extended-Release Tablets CII

17 Jul 2017

Company expects to launch by the end of the year.

Read more 
Alzheon presents new data for ALZ-801 on novel MOA and long-term clinical efficacy at the AAIC

Alzheon presents new data for ALZ-801 on novel MOA and long-term clinical efficacy at the AAIC

17 Jul 2017

Presentations highlight recent discovery of inhibition of formation of toxic beta amyloid oligomers and new insights for Precision Medicine approach for ALZ-801 targeting APOE4 carriers.

Read more 
Ground-breaking preclinical data to be presented at AAIC 2017

Ground-breaking preclinical data to be presented at AAIC 2017

16 Jul 2017

KalGene’s Alzheimer’s therapeutics candidate, licensed from the NRC (KAL-ABP-BBB), crosses the blood-brain barrier, and reduces amyloid-beta burden in a transgenic rat model after a 4-week treatment.

Read more